Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Eli Lilly, Novo Nordisk and Sanofi face new lawsuit from Arkansas AG over insulin prices
Fierce Pharma
Thu, 05/12/22 - 10:54 pm
Eli Lilly
Novo Nordisk
Sanofi
Arkansas
insulin
drug pricing
PBMs
diabetes
How Novo Nordisk Will Protect Insulin Sales
Motley Fool
Thu, 05/12/22 - 10:27 am
Novo Nordisk
insulin
diabetes
drug pricing
Affordable Insulin Now Act
Weigh to Go: Gelesis Boasts Positive Results for Weight Loss Treatment
BioSpace
Thu, 05/5/22 - 10:24 am
PureTech Health
Gelesis Holdings
clinical trials
GS200
diabetes
obesity
weight loss
The next generation of diabetes technology
EP Vantage
Wed, 05/4/22 - 10:19 am
Medtech
devices
diabetes
Abbott Labs
DexCom
Insulet
Tandem Diabetes
Ypsomed
Medtronic
Dexcom’s CEO: FDA’s Nod for G7 Could Come Sometime After ADA
Medical Devices and Diagnostics Industry
Fri, 04/29/22 - 10:42 am
DexCom
G7
continuous glucose monitoring
diabetes
FDA
Medtech
devices
Novo Nordisk once-weekly insulin clears first phase 3 test
Pharmaforum
Fri, 04/29/22 - 10:33 am
Novo Nordisk
diabetes
type 2 diabetes
insulin
insulin icodec
once-weekly insulin
clinical trials
Abbott joins alliance to bring ‘artificial pancreas’ system to Europe
Pharmaforum
Thu, 04/28/22 - 10:49 am
Abbott Labs
diabetes
Medtech
automated insulin delivery
artificial pancreas
Europe
Camdiab
Ypsomed
Why the drug pricing debate is focused on insulin
Pharmaforum
Wed, 04/13/22 - 10:48 am
diabetes
insulin
drug pricing
The mysterious case of Viatris and the missing insulin label deepens
Fierce Pharma
Wed, 04/13/22 - 10:42 am
Viatris
insulin
diabetes
biosimilars
Sanofi
Lantus
product recalls
Embecta seeks high growth with low tech
EP Vantage
Wed, 04/6/22 - 11:39 am
Embecta
Medtech
devices
diabetes
Becton Dickinson
spinoffs
injectors
Fractyl Wins FDA Nod for New Revita Pivotal Study
Medical Devices and Diagnostics Industry
Mon, 04/4/22 - 11:17 pm
Medtech
DMR systems
Fractyl Labs
diabetes
Revita DMR
ACC: Lexicon hopes sotagliflozin cardio data will set its drug apart from SGLT2 rivals
Fierce Pharma
Mon, 04/4/22 - 10:59 am
Lexicon Pharmaceuticals
ACC
diabetes
sotagliflozin
type 2 diabetes
heart failure
$35 monthly insulin cap: Republicans decry how White House, Dems plan to pay for it
Endpoints
Thu, 03/31/22 - 10:35 am
drug pricing
price caps
insulin
diabetes
Joe Biden
Novo Nordisk snags high-dose Ozempic approval, turning up the heat on Lilly's Trulicity
Fierce Pharma
Wed, 03/30/22 - 11:11 am
Novo Nordisk
Ozempic
diabetes
FDA
Eli Lilly
Trulicity
U.S. Senate to Take Up Proposed $35 Insulin Cap this Spring
BioSpace
Mon, 03/28/22 - 07:54 pm
Senate
diabetes
insulin
price caps
drug pricing
Novo Nordisk and Novartis put Victoza patent suit to bed, teeing up Sandoz copycat by 2024
Fierce Pharma
Wed, 03/23/22 - 10:38 am
Novo Nordisk
Novartis
Sandoz
Victoza
generics
patents
diabetes
Insulin price caps on the horizon as Senate leader plans vote
Pharmaforum
Wed, 03/23/22 - 10:33 am
Senate
insulin
diabetes
drug pricing
Joe Biden
price caps
Diabetes data put Better Therapeutics’ digital offering on track for FDA filing
MedCity News
Wed, 03/16/22 - 10:07 am
Better Therapeutics
digital health
digital pharma
Medtech
digital therapeutics
diabetes
FDA
Civica aims to launch low-cost insulin in U.S. by 2024
Yahoo/Reuters
Thu, 03/3/22 - 10:17 am
Civica Rx
insulin
diabetes
non-profits
Medtronic talks diabetes group's FDA warning letter, new products, supply chain constraints
Medtech Dive
Mon, 02/21/22 - 10:40 am
Medtronic
diabetes
FDA
warning letter
devices
Medtech
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »